Cargando…

Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer

As a clinically heterogeneous subtype of breast cancer, triple-negative breast cancer (TNBC) is associated with a poor clinical outcome and a high relapse rate. Conventional chemotherapy and radiotherapy are effective treatments for patients with TNBC. However, the prognosis of TNBC remains unsatisf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Nan, Zhang, Jinghua, Zhao, Jing, Mu, Kun, Zhang, Jun, Jin, Zhao, Yu, Jinpu, Liu, Juntian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144355/ https://www.ncbi.nlm.nih.gov/pubmed/30250564 http://dx.doi.org/10.3892/ol.2018.9290

Ejemplares similares

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
por: Xiao, Yi, et al.
Publicado: (2022)

β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
por: Xu, Jinhua, et al.
Publicado: (2015)

Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
por: Hossain, Fokhrul, et al.
Publicado: (2021)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Drug Repositioning and Subgroup Discovery for Precision Medicine Implementation in Triple Negative Breast Cancer
por: Al-Taie, Zainab, et al.
Publicado: (2021)

Short-Term Environmental Conditioning Enhances Tumorigenic Potential of Triple-Negative Breast Cancer Cells
por: Eckley, Samantha S., et al.
Publicado: (2019)

Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
por: Subhan, Md Abdus, et al.
Publicado: (2023)

MicroRNA-139 Suppresses the Tumorigenicity of Triple Negative Breast Cancer Cells by Targeting SOX8
por: Dong, Liangliang, et al.
Publicado: (2020)

PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer
por: Chen, Chunhua, et al.
Publicado: (2021)

Development and characterization of two human triple‐negative breast cancer cell lines with highly tumorigenic and metastatic capabilities
por: Su, Yanrong, et al.
Publicado: (2016)

Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers
por: Di Mauro, Concetta, et al.
Publicado: (2017)

Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells
por: Ozawa, Patricia Midori Murobushi, et al.
Publicado: (2018)

GPRC5A Is a Negative Regulator of the Pro-Survival PI3K/Akt Signaling Pathway in Triple-Negative Breast Cancer
por: Yang, Lu, et al.
Publicado: (2021)

Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer
por: Zhao, Wenjie, et al.
Publicado: (2021)

The value of FATS expression in predicting sensitivity to radiotherapy in breast cancer
por: Zhang, Jun, et al.
Publicado: (2017)

Eupalinolide J Suppresses the Growth of Triple-Negative Breast Cancer Cells via Targeting STAT3 Signaling Pathway
por: Lou, Chenghua, et al.
Publicado: (2019)

Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth
por: Zhao, Hongting, et al.
Publicado: (2023)

Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer
por: Xu, Jiangsheng, et al.
Publicado: (2019)

Sulforaphane suppresses metastasis of triple-negative breast cancer cells by targeting the RAF/MEK/ERK pathway
por: Zhang, Ying, et al.
Publicado: (2022)

The hedgehog pathway in triple‐negative breast cancer
por: Habib, Joyce G., et al.
Publicado: (2016)

Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
por: Dewi, Citra, et al.
Publicado: (2022)

Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic‐associated molecular subtypes and genomic mutations
por: Li, Lijuan, et al.
Publicado: (2023)

Wnt signaling in triple-negative breast cancer
por: Pohl, SÖ-G, et al.
Publicado: (2017)

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial
por: Jiang, Yi-Zhou, et al.
Publicado: (2020)

The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer
por: Divoux, Jordane, et al.
Publicado: (2023)

C/EBPβ regulates the JAK/STAT signaling pathway in triple‐negative breast cancer
por: Wang, Shu, et al.
Publicado: (2021)

Precision Breast Cancer Medicine: Early Stage Triple Negative Breast Cancer—A Review of Molecular Characterisation, Therapeutic Targets and Future Trends
por: Pinilla, Karen, et al.
Publicado: (2022)

Targeted therapy for metastatic triple negative breast cancer: The next frontier in precision oncology
por: Vidula, Neelima, et al.
Publicado: (2017)

Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1–TAZ Signaling Pathway
por: Kong, Lu, et al.
Publicado: (2022)

Systems Medicine Design for Triple-Negative Breast Cancer and Non-Triple-Negative Breast Cancer Based on Systems Identification and Carcinogenic Mechanisms
por: Yeh, Shan-Ju, et al.
Publicado: (2021)

Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway
por: Yang, Ting, et al.
Publicado: (2021)

Salvia chinensis Benth Inhibits Triple-Negative Breast Cancer Progression by Inducing the DNA Damage Pathway
por: Wang, Kai-nan, et al.
Publicado: (2022)

Identification of potential key genes and pathways predicting pathogenesis and prognosis for triple-negative breast cancer
por: Lv, Xuemei, et al.
Publicado: (2019)

Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway
por: Qi, Yufeng, et al.
Publicado: (2023)

CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer
por: Cheng, Tianyi, et al.
Publicado: (2022)

Outcomes of Immediate Breast Reconstruction in Triple Negative Breast Cancer
por: Grigor, Emma, et al.
Publicado: (2021)

Inhibition of IGF signalling pathway in MDA-MB-231 triple negative breast cancer cells
por: Chandran, S, et al.
Publicado: (2012)

LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women
por: Torres-Luquis, Odalys, et al.
Publicado: (2018)

BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways
por: Zhang, Yang, et al.
Publicado: (2020)

Thioguanine Induces Apoptosis in Triple-Negative Breast Cancer by Regulating PI3K–AKT Pathway
por: Zhang, Daoyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ejb9kllhcsoi7cpejs0c9q2qbm